• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2017-2018 年印度麻疹-风疹补充免疫活动准备情况评估。

Measles-Rubella Supplementary Immunization Activity Readiness Assessment - India, 2017-2018.

出版信息

MMWR Morb Mortal Wkly Rep. 2018 Jul 6;67(26):742-746. doi: 10.15585/mmwr.mm6726a3.

DOI:10.15585/mmwr.mm6726a3
PMID:29975677
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6048977/
Abstract

In 2013, during the 66th session of the Regional Committee of the World Health Organization (WHO) South-East Asia Region (SEAR), the 11 SEAR countries* adopted goals to eliminate measles and control rubella and congenital rubella syndrome by 2020 (1). To accelerate progress in India (2,3), a phased nationwide supplementary immunization activity (SIA) using measles-rubella vaccine and targeting approximately 410 million children aged 9 months-14 years commenced in 2017 and will be completed by first quarter of 2019. To ensure a high-quality SIA, planning and preparation were monitored using a readiness assessment tool adapted from the WHO global field guide** (4) by the India Ministry of Health and Family Welfare. This report describes the results and experience gained from conducting SIA readiness assessments in 24 districts of three Indian states (Andhra Pradesh, Kerala, and Telangana) during the second phase of the SIA. In each selected area, assessments were conducted 4-6 weeks and 1-2 weeks before the scheduled SIA. At the first assessment, none of the states and districts were on track with preparations for the SIA. However, at the second assessment, two (67%) states and 21 (88%) districts were on track. The SIA readiness assessment identified several preparedness gaps; early assessment results were immediately communicated to authorities and led to necessary corrective actions to ensure high-quality SIA implementation.

摘要

2013 年,在第 66 届世界卫生组织(世卫组织)东南亚区域委员会(东南亚区域)会议期间,11 个东南亚区域国家*通过了到 2020 年消除麻疹和控制风疹及先天性风疹综合征的目标(1)。为加快印度的进展(2,3),2017 年开始在全国分阶段开展使用麻疹-风疹疫苗的补充免疫活动(SIA),目标人群为约 4.10 亿 9 月龄-14 岁儿童,并将于 2019 年第一季度完成(2,3)。为确保 SIA 高质量实施,印度卫生和家庭福利部使用世卫组织全球现场指南(4)中的准备情况评估工具对规划和筹备情况进行监测(4)。本报告介绍了在印度三个邦(安得拉邦、喀拉拉邦和特伦甘纳邦)的 24 个地区开展 SIA 准备情况评估的结果和经验,这些地区是 SIA 的第二阶段。在每个选定地区,评估在 SIA 前 4-6 周和 1-2 周进行。第一次评估时,没有一个邦和地区的准备工作符合 SIA 要求。然而,第二次评估时,两个邦(67%)和 21 个区(88%)符合要求。SIA 准备情况评估发现了一些准备差距;早期评估结果立即通报给当局,并采取必要的纠正措施,以确保 SIA 高质量实施。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e879/6048977/cfc19b24f90d/mm6726a3-F.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e879/6048977/cfc19b24f90d/mm6726a3-F.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e879/6048977/cfc19b24f90d/mm6726a3-F.jpg

相似文献

1
Measles-Rubella Supplementary Immunization Activity Readiness Assessment - India, 2017-2018.2017-2018 年印度麻疹-风疹补充免疫活动准备情况评估。
MMWR Morb Mortal Wkly Rep. 2018 Jul 6;67(26):742-746. doi: 10.15585/mmwr.mm6726a3.
2
Progress Toward Measles and Rubella Elimination - India, 2005-2021.迈向消除麻疹和风疹的进展 - 印度,2005-2021 年。
MMWR Morb Mortal Wkly Rep. 2022 Dec 16;71(50):1569-1575. doi: 10.15585/mmwr.mm7150a1.
3
Progress Toward Rubella and Congenital Rubella Syndrome Control - South-East Asia Region, 2000-2016.《2000-2016 年东南亚区域风疹和先天性风疹综合征控制进展》。
MMWR Morb Mortal Wkly Rep. 2018 Jun 1;67(21):602-606. doi: 10.15585/mmwr.mm6721a3.
4
Status of coverage of MR vaccination, after supplementary immunization activities in a rural area of South India: a rapid immunization coverage survey.印度南部农村地区开展补充免疫活动后麻疹风疹疫苗接种覆盖率情况:一项快速免疫接种覆盖率调查
Rural Remote Health. 2019 Sep;19(3):5261. doi: 10.22605/RRH5261. Epub 2019 Sep 18.
5
Real-Time Monitoring of Vaccination Campaign Performance Using Mobile Phones - Nepal, 2016.利用手机实时监测疫苗接种活动执行情况 - 尼泊尔,2016 年。
MMWR Morb Mortal Wkly Rep. 2016 Oct 7;65(39):1072-1076. doi: 10.15585/mmwr.mm6539a5.
6
Progress Toward Measles Elimination - Bangladesh, 2000-2016.2000 - 2016年孟加拉国在消除麻疹方面取得的进展
MMWR Morb Mortal Wkly Rep. 2017 Jul 21;66(28):753-757. doi: 10.15585/mmwr.mm6628a3.
7
Measles-rubella mass immunization campaign in Albania, November 2000.2000年11月在阿尔巴尼亚开展的麻疹-风疹大规模免疫接种运动。
J Infect Dis. 2003 May 15;187 Suppl 1:S223-9. doi: 10.1086/368055.
8
Progress in measles and rubella elimination in Iran.伊朗在消除麻疹和风疹方面取得的进展。
Pediatr Infect Dis J. 2007 Dec;26(12):1137-41. doi: 10.1097/INF.0b013e3181462090.
9
Measles and rubella vaccination coverage in Haiti, 2012: progress towards verifying and challenges to maintaining measles and rubella elimination.2012 年海地的麻疹和风疹疫苗接种覆盖率:核实进展和维持麻疹和风疹消除的挑战。
Trop Med Int Health. 2014 Sep;19(9):1105-15. doi: 10.1111/tmi.12335. Epub 2014 Jul 16.
10
Progress Toward Measles Elimination - South-East Asia Region, 2003-2020.迈向消除麻疹的进展 - 东南亚区域,2003-2020 年。
MMWR Morb Mortal Wkly Rep. 2022 Aug 19;71(33):1042-1046. doi: 10.15585/mmwr.mm7133a2.

引用本文的文献

1
Increased measles and rubella seroprevalence in children using residual blood samples from health facilities and household serosurveys after supplementary immunization activities in two districts in India.在印度两个地区开展补充免疫活动后,利用卫生机构的剩余血样和家庭血清学调查,儿童麻疹和风疹血清阳性率上升。
Epidemiol Infect. 2024 Nov 18;152:e143. doi: 10.1017/S0950268824001353.
2
Identifying factors that can be used to assess a country's readiness to deploy a new vaccine or improve uptake of an underutilised vaccine: a scoping review.确定可用于评估一个国家部署新疫苗或提高未充分利用疫苗接种率准备情况的因素:范围综述。
BMJ Open. 2024 May 7;14(5):e080370. doi: 10.1136/bmjopen-2023-080370.
3

本文引用的文献

1
Progress Toward Regional Measles Elimination - Worldwide, 2000-2016.2000 - 2016年全球区域消除麻疹进展
MMWR Morb Mortal Wkly Rep. 2017 Oct 27;66(42):1148-1153. doi: 10.15585/mmwr.mm6642a6.
Post-campaign coverage evaluation of a measles and rubella supplementary immunization activity in five districts in India, 2019-2020.
2019-2020 年印度五个地区开展的麻疹和风疹补充免疫活动的活动后覆盖情况评估。
PLoS One. 2024 Mar 29;19(3):e0297385. doi: 10.1371/journal.pone.0297385. eCollection 2024.
4
Maternally transmitted anti-measles antibodies, and susceptibility to disease among infants in Chandigarh, India: A prospective birth cohort study.母传麻疹抗体与印度昌迪加尔婴儿疾病易感性:一项前瞻性出生队列研究。
PLoS One. 2023 Oct 3;18(10):e0287110. doi: 10.1371/journal.pone.0287110. eCollection 2023.
5
Understanding determinants of vaccine hesitancy and acceptance in India: A qualitative study of government officials and civil society stakeholders.了解印度疫苗犹豫和接受的决定因素:对政府官员和民间社会利益相关者的定性研究。
PLoS One. 2022 Jun 9;17(6):e0269606. doi: 10.1371/journal.pone.0269606. eCollection 2022.
6
Burden of congenital rubella syndrome (CRS) in India based on data from cross-sectional serosurveys, 2017 and 2019-20.基于 2017 年和 2019-2020 年横断面血清学调查数据的印度先天性风疹综合征(CRS)负担。
PLoS Negl Trop Dis. 2021 Jul 23;15(7):e0009608. doi: 10.1371/journal.pntd.0009608. eCollection 2021 Jul.
7
Epidemiology of Congenital Rubella Syndrome (CRS) in India, 2016-18, based on data from sentinel surveillance.基于哨点监测数据的 2016-2018 年印度先天性风疹综合征(CRS)流行病学研究。
PLoS Negl Trop Dis. 2020 Feb 3;14(2):e0007982. doi: 10.1371/journal.pntd.0007982. eCollection 2020 Feb.